Report Highlights
Oligonucleotide Synthesis Market Size And Forecast
Oligonucleotide Synthesis Market was valued at USD 1.71 Billion in 2019 and is projected to reach USD 3.58 Billion by 2027, growing at a CAGR of 10.45% from 2020 to 2027.
Oligonucleotide Synthesis Market Overview
The increased prevalence of synthesized oligos used in molecular diagnostics and clinical applications is the factor for rise in market growth. Oligos are chemically synthesized, and are applied in many relevant areas of scientific research and development. These have become a point of focus in Molecular Biology and Biotechnology, due to the synthetic DNA and cell-made DNA having similar structural and chemical qualities. The antisense oligonucleotides are applied to reduce the stages of protein synthesis by suppressing Micro RNA translation. This method is foundation of many therapies which are undergoing clinical trials for a variety of cancer treatments. The role of favorable favorable government initiatives for the funding, and increased Research and Development disbursements in Pharmaceutical and Biotechnology Companies are causing a surge in the market revenue.
The restraints observed are the increased costs and investments in synthesized oligos. There is dearth of rules and regulations for safe use of synthesized oligos. The lack of increased wages of skilled employees and technicians, scarcity of skilled professional and expertise to handle the synthesized oligos. The challenges faced are the Antisense Oligonucleotide undergoing delayed supply chain. There are flaws in synthesis methods which sharply reduce the amount of available drug substance, analytical methods are not well developed. It is quite cumbersome to handle the oligos synthesized on a large scale, and the delivery of oligonucleotides to specific targets still remains a drawback.
Global Oligonucleotide Synthesis Market Segmentation Analysis:
The Global Oligonucleotide Synthesis Market is segmented on the basis of Products & Services, Application, End-User and Geography
Oligonucleotide Synthesis Market Competitive Landscape
The Global Oligonucleotide Synthesis Market study report offers a valuable insight with an emphasis on global market including some of the major players such Integrated DNA Technologies, Inc., Merck KGaA, Eurofins Genomics, BioAutomation, Agilent Technologies Inc., Eurogentec S.A., General Electric Company, Thermo Fisher Scientific, Inc., Biosearch Technologies, and Nitto Denko Avecia Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Similar Reports from Verified Market Research
Global Oligonucleotide Synthesis Market
Oligonucleotide Synthesis Market Size And Forecast
Oligonucleotide Synthesis Market was valued at USD 1.71 billion in 2019 and is projected to reach USD 3.58 billion by 2027, growing at a CAGR of 10.45% from 2020 to 2027.
Global Oligonucleotide Synthesis Market
The global Oligonucleotide Synthesis Market was valued at USD 1.28 billion in 2016 and is projected to reach USD 3.15 billion by 2025, growing at a CAGR of 10.45% from 2017 to 2025.
Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More